Boulder Diagnostics - Ownership and Business Overview

Medical ProductsCompany

Boulder Diagnostics Ownership

Who owns Boulder Diagnostics?

Boulder Diagnostics is owned by Oxford Immunotec Global. It was acquired on August 5, 2014.

Boulder Diagnostics Business Overview

Where is Boulder Diagnostics headquartered?

Boulder Diagnostics is headquartered in Boulder, Colorado.

What sector is Boulder Diagnostics in?

Boulder Diagnostics is a medical products company.

Medical Products M&A Summary in 2014

Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2014. The largest medical products acquisition in 2014 was Covidien - which was acquired by Medtronic for $42.9B.

Join Mergr to view all 216 acquisitions of medical products companies in 2014, including 23 acquisitions by private equity firms, and 193 by strategics.

Boulder Diagnostics, Inc.

6395 Gunpark Drive,
Boulder, Colorado 80301
United States,
(720) 897-6276
www.oxfordimmunotec.com/north-america/boulder-diagnostics

Boulder Diagnostics is a private diagnostics company based in Boulder, Colorado that is developing immunology-based assays for rheumatology and infectious diseases. The primary focus of Boulder Diagnostics is on three products: Spirofind an assay to assist in the diagnosis of Lyme disease in both early and late-presenting forms, GoutifindTM an assay to assist in the diagnosis of Gout, obviating diagnosis by joint puncture, and StratokineTM an assay to help select biologics for autoimmune disease based on monitoring and prognosis of drug response.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.